Jiuqiang Biotech announced that the company recently received the “Medical Device Registration Certificate” issued by the Beijing Drug Administration. The product is a type I collagen amino terminal lengthening peptide test kit. The registration category is Class II. The registration certificate is valid from the date of approval until September 8, 2031, and is used to quantitatively measure the content of type I collagen amino terminal lengthening peptides in human serum or plasma in vitro. The acquisition of this registration certificate has enriched the company's product line in the in vitro diagnostic chemiluminescence segment, which is conducive to enhancing core competitiveness and market expansion capabilities, and its impact on future performance cannot yet be predicted.

Jiuqiang Biotech announced that the company recently received the “Medical Device Registration Certificate” issued by the Beijing Drug Administration. The product is a type I collagen amino terminal lengthening peptide test kit. The registration category is Class II. The registration certificate is valid from the date of approval until September 8, 2031, and is used to quantitatively measure the content of type I collagen amino terminal lengthening peptides in human serum or plasma in vitro. The acquisition of this registration certificate has enriched the company's product line in the in vitro diagnostic chemiluminescence segment, which is conducive to enhancing core competitiveness and market expansion capabilities, and its impact on future performance cannot yet be predicted.